When does Zelboraf’s (vemurafenib) European patent protection expire in Feb 2027?
The specific date “Feb 2027” does not map to a single, clearly identified Zelboraf (vemurafenib) patent-expiry fact in the information provided here. Patent protection timelines in Europe depend on which right you mean (basic patent vs. supplementary protection certificate (SPC) vs. market exclusivity/paediatric extensions), and on the exact patent family and country coverage being queried.
What determines the actual expiry date for Zelboraf in Europe?
In practice, “patent protection” dates can be driven by several different legal instruments:
- The expiry of the relevant basic European patent(s) in the country(ies) concerned.
- SPC expiry (if an SPC was granted for vemurafenib based on the marketing authorization).
- Any additional paediatric extension (where applicable) tied to regulatory status.
- Whether competitors are cleared by “patent expiry” or by the outcome of patent disputes (see next section).
Because these elements are all different, two sources can cite different “expiry” dates for the same product if they refer to different legal protections.
Could competitors enter before Feb 2027 even if a patent expires then?
Yes. Even if one protection expires in or around Feb 2027, generic and biosimilar-style entry (for small molecules like vemurafenib, generics rather than biosimilars) can still be affected by:
- Remaining active patents in the same family or related families (including method-of-use patents).
- Court rulings in patent litigation.
- Launch timing strategies that reflect when product supply can begin without infringing.
So the practical “can they launch?” date can differ from the “one patent expires” date.
How to verify the exact European expiry date you mean
To pin down “Zelboraf patent protection Europe Feb 2027,” you generally need:
- The specific patent number or patent family (or at least the assignee and key invention type, such as substance, formulation, or method of treatment).
- The country in Europe you care about (EP validations differ by country).
- Confirmation whether you are looking for basic patent expiry or SPC expiry (or both).
If you share any of the following, the “Feb 2027” date can be checked precisely against the correct protection type:
- the patent number/family name you have in mind, or
- whether you mean SPC expiry, and/or
- the country (e.g., UK, DE, FR, ES) plus whether you have an EP number.
Sources
No sources were provided in the prompt, so no citations can be included.